TickerFacts.

A business in context

AMGN research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-11 · 0000318154-26-000137

  2. 4 · Ownership change

    Report date 2026-08-07 · 0000318154-26-000135

  3. 4 · Ownership change

    Report date 2026-08-07 · 0000318154-26-000133

  4. 4 · Ownership change

    Report date 2026-08-07 · 0000318154-26-000132

  5. 4 · Ownership change

    Report date 2026-08-07 · 0000318154-26-000131

  6. 4 · Ownership change

    Report date 2026-08-06 · 0000318154-26-000130

  7. 4 · Ownership change

    Report date 2026-08-06 · 0000318154-26-000129

  8. 10-Q · Quarterly report

    Report date 2026-06-30 · 0000318154-26-000126

  9. 8-K · Current report

    Report date 2026-08-04 · 0000318154-26-000124 · Items 2.02,9.01

  10. 8-K · Current report

    Report date 2026-07-29 · 0000318154-26-000119 · Items 1.05

  11. 4 · Ownership change

    Report date 2026-05-19 · 0000318154-26-000108

  12. 8-K · Current report

    Report date 2026-05-19 · 0001193125-26-232786 · Items 5.07

  13. 8-K · Current report

    Report date 2026-05-19 · 0000318154-26-000097 · Items 5.02

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0000318154-26-000057

  15. 8-K · Current report

    Report date 2026-04-30 · 0000318154-26-000054 · Items 2.02,9.01

  16. 8-K · Current report

    Report date 2026-04-22 · 0000318154-26-000048 · Items 5.02,9.01

  17. DEF 14A · Proxy statement

    Report date 2026-05-19 · 0001193125-26-145588

  18. 8-K · Current report

    Report date 2026-02-17 · 0001193125-26-059490 · Items 1.01,9.01

  19. 10-K · Annual report

    Report date 2025-12-31 · 0000318154-26-000010

  20. 8-K · Current report

    Report date 2026-02-03 · 0000318154-26-000003 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2026-01-30 · 0001193125-26-030518 · Items 1.02,9.01

  22. 10-Q · Quarterly report

    Report date 2025-09-30 · 0000318154-25-000072

  23. 8-K · Current report

    Report date 2025-11-04 · 0000318154-25-000070 · Items 2.02,9.01

  24. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000318154-25-000056

  25. 8-K · Current report

    Report date 2025-08-05 · 0000318154-25-000054 · Items 2.02,9.01

  26. 8-K · Current report

    Report date 2025-05-23 · 0000950170-25-077233 · Items 5.07

  27. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000318154-25-000020

  28. 8-K · Current report

    Report date 2025-05-01 · 0000318154-25-000018 · Items 2.02,9.01

  29. DEF 14A · Proxy statement

    Report date 2025-05-23 · 0000950170-25-052315

  30. 10-K · Annual report

    Report date 2024-12-31 · 0000318154-25-000010

  31. 8-K · Current report

    Report date 2025-02-04 · 0000318154-25-000005 · Items 2.02,9.01

  32. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000318154-24-000044

  33. 8-K · Current report

    Report date 2024-10-30 · 0000318154-24-000042 · Items 2.02,9.01

  34. SC 13G/A · Ownership disclosure

    0001193125-24-206196

  35. 10-Q · Quarterly report

    Report date 2024-06-30 · 0000318154-24-000035

  36. 8-K · Current report

    Report date 2024-08-06 · 0000318154-24-000033 · Items 2.02,9.01

  37. 8-K · Current report

    Report date 2024-05-31 · 0001193125-24-153221 · Items 5.02,5.07

  38. 10-Q · Quarterly report

    Report date 2024-03-31 · 0000318154-24-000020

  39. 8-K · Current report

    Report date 2024-05-02 · 0000318154-24-000018 · Items 2.02,9.01

  40. DEF 14A · Proxy statement

    Report date 2024-05-31 · 0001193125-24-099062

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 1 transaction rows1SGrant / award: 36 transaction rows36AExercise / conversion: 0 transaction rows0MTax / exercise payment: 42 transaction rows42FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

79 matching transaction rows. Showing 1–50.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-05-19
2026-05-21
MILES AMY EA · Grant / award
Acquired
Common Stock665.00.0
2026-05-19
2026-05-21
Kullman Ellen JamisonA · Grant / award
Acquired
Common Stock665.00.0
2026-05-19
2026-05-21
Klotman Mary E.A · Grant / award
Acquired
Common Stock665.00.0
2026-05-19
2026-05-21
Jacks TylerA · Grant / award
Acquired
Common Stock665.00.0
2026-05-19
2026-05-21
ISHRAK OMARA · Grant / award
Acquired
Common Stock665.00.0
2026-05-19
2026-05-21
HOLLEY CHARLES MA · Grant / award
Acquired
Common Stock665.00.0
2026-05-19
2026-05-21
Garland Greg C.A · Grant / award
Acquired
Common Stock665.00.0
2026-05-19
2026-05-21
ECKERT ROBERTA · Grant / award
Acquired
Common Stock665.00.0
2026-05-19
2026-05-21
Druker BrianA · Grant / award
Acquired
Common Stock665.00.0
2026-05-19
2026-05-21
Drake Michael VA · Grant / award
Acquired
Common Stock665.00.0
2026-05-19
2026-05-21
Austin Wanda MA · Grant / award
Acquired
Common Stock665.00.0
2026-05-07
2026-05-11
Busch Matthew C.F · Tax / exercise payment
Disposed
Common Stock41.0331.11
2026-05-07
2026-05-11
Santos EstebanF · Tax / exercise payment
Disposed
Common Stock522.0331.11
2026-05-07
2026-05-11
REESE DAVID MF · Tax / exercise payment
Disposed
Common Stock556.0331.11
2026-05-07
2026-05-11
Miller DerekF · Tax / exercise payment
Disposed
Common Stock151.0331.11
2026-05-07
2026-05-11
Khosla RachnaF · Tax / exercise payment
Disposed
Common Stock93.0331.11
2026-05-07
2026-05-11
Grygiel Nancy A.F · Tax / exercise payment
Disposed
Common Stock88.0331.11
2026-05-07
2026-05-11
Griffith Peter H.F · Tax / exercise payment
Disposed
Common Stock556.0331.11
2026-05-07
2026-05-11
Graham Jonathan PF · Tax / exercise payment
Disposed
Common Stock499.0331.11
2026-05-07
2026-05-11
Gordon MurdoF · Tax / exercise payment
Disposed
Common Stock615.0331.11
2026-05-07
2026-05-11
Bradway Robert AF · Tax / exercise payment
Disposed
Common Stock2079.0331.11
2026-05-07
2026-05-11
Bradner James E.F · Tax / exercise payment
Disposed
Common Stock446.0331.11
2026-05-06
2026-05-07
Bradner James E.F · Tax / exercise payment
Disposed
Common Stock407.0329.59
2026-05-06
2026-05-07
Bradway Robert AF · Tax / exercise payment
Disposed
Common Stock1702.0329.59
2026-05-06
2026-05-07
Busch Matthew C.F · Tax / exercise payment
Disposed
Common Stock50.0329.59
2026-05-06
2026-05-07
Gordon MurdoF · Tax / exercise payment
Disposed
Common Stock502.0329.59
2026-05-06
2026-05-07
Graham Jonathan PF · Tax / exercise payment
Disposed
Common Stock408.0329.59
2026-05-06
2026-05-07
Griffith Peter H.F · Tax / exercise payment
Disposed
Common Stock502.0329.59
2026-05-06
2026-05-07
Grygiel Nancy A.F · Tax / exercise payment
Disposed
Common Stock76.0329.59
2026-05-06
2026-05-07
Khosla RachnaF · Tax / exercise payment
Disposed
Common Stock79.0329.59
2026-05-06
2026-05-07
Miller DerekF · Tax / exercise payment
Disposed
Common Stock123.0329.59
2026-05-06
2026-05-07
REESE DAVID MF · Tax / exercise payment
Disposed
Common Stock454.0329.59
2026-05-06
2026-05-07
Santos EstebanF · Tax / exercise payment
Disposed
Common Stock427.0329.59
2026-05-05
2026-05-07
Bradner James E.A · Grant / award
Acquired
Common Stock3337.00.0
2026-05-05
2026-05-07
Bradner James E.A · Grant / award
Acquired
Nqso (Right to Buy)
Derivative security
21773.0329.59
2026-05-05
2026-05-07
Bradway Robert AA · Grant / award
Acquired
Common Stock12136.00.0
2026-05-05
2026-05-07
Bradway Robert AA · Grant / award
Acquired
Nqso (Right to Buy)
Derivative security
79176.0329.59
2026-05-05
2026-05-07
Busch Matthew C.A · Grant / award
Acquired
Common Stock455.00.0
2026-05-05
2026-05-07
Busch Matthew C.A · Grant / award
Acquired
Nqso (Right to Buy)
Derivative security
2969.0329.59
2026-05-05
2026-05-07
Gordon MurdoA · Grant / award
Acquired
Common Stock3640.00.0
2026-05-05
2026-05-07
Gordon MurdoA · Grant / award
Acquired
Nqso (Right to Buy)
Derivative security
23752.0329.59
2026-05-05
2026-05-07
Graham Jonathan PA · Grant / award
Acquired
Common Stock2609.00.0
2026-05-05
2026-05-07
Graham Jonathan PA · Grant / award
Acquired
Nqso (Right to Buy)
Derivative security
17022.0329.59
2026-05-05
2026-05-07
Griffith Peter H.A · Grant / award
Acquired
Common Stock3640.00.0
2026-05-05
2026-05-07
Griffith Peter H.A · Grant / award
Acquired
Nqso (Right to Buy)
Derivative security
23752.0329.59
2026-05-05
2026-05-07
Grygiel Nancy A.A · Grant / award
Acquired
Common Stock485.00.0
2026-05-05
2026-05-07
Grygiel Nancy A.A · Grant / award
Acquired
Nqso (Right to Buy)
Derivative security
3167.0329.59
2026-05-05
2026-05-07
Khosla RachnaA · Grant / award
Acquired
Common Stock500.00.0
2026-05-05
2026-05-07
Khosla RachnaA · Grant / award
Acquired
Nqso (Right to Buy)
Derivative security
3266.0329.59
2026-05-05
2026-05-07
Miller DerekA · Grant / award
Acquired
Common Stock910.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000318154AMGEN INC
Applied Molecular GeneticsAmgen (Germany)Amgen (Netherlands)Amgen (France)

Showing 4 of 4 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Amgen · alias · wikidata
  • Applied Molecular Genetics · subsidiary · wikidata
  • Amgen (Canada) · subsidiary · wikidata
  • Amgen (Germany) · subsidiary · wikidata
  • Amgen (Netherlands) · subsidiary · wikidata
  • Amgen (France) · subsidiary · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$33.42B$35.58B
2023-12-31$28.19B$30.89B
2022-12-31$26.32B$30.03B
2021-12-31$25.98B$32.01B
2020-12-31$25.42B$32.80B
2019-12-31$23.36B$30.51B

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗